These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 34264407)
41. Gut Microbiome of Children and Adolescents With Primary Sclerosing Cholangitis in Association With Ulcerative Colitis. Cortez RV; Moreira LN; Padilha M; Bibas MD; Toma RK; Porta G; Taddei CR Front Immunol; 2020; 11():598152. PubMed ID: 33613519 [TBL] [Abstract][Full Text] [Related]
42. The variation characteristics of fecal microbiota in remission UC patients with anxiety and depression. Xu L; Li Y; He Y Front Microbiol; 2023; 14():1237256. PubMed ID: 37744915 [TBL] [Abstract][Full Text] [Related]
43. Nigella A ameliorates inflammation and intestinal flora imbalance in DSS induced colitis mice. Hu X; Xu N; Yang X; Hu X; Zheng Y; Zhang Q AMB Express; 2020 Oct; 10(1):179. PubMed ID: 33011900 [TBL] [Abstract][Full Text] [Related]
44. Intestinal flora alterations in patients with early chronic kidney disease: a case-control study among the Han population in southwestern China. Hu Q; Wu K; Pan W; Zeng Y; Hu K; Chen D; Huang X; Zhang Q J Int Med Res; 2020 Jun; 48(6):300060520926033. PubMed ID: 32495708 [TBL] [Abstract][Full Text] [Related]
45. MIR-21 regulating distribution of intestinal flora through TNF-α promotes progression of ulcerative colitis. Ke Y; Liu X; Niu T; Qiang Z; Gao F J Med Biochem; 2024 Apr; 43(2):299-305. PubMed ID: 38699693 [TBL] [Abstract][Full Text] [Related]
46. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis. Bajer L; Kverka M; Kostovcik M; Macinga P; Dvorak J; Stehlikova Z; Brezina J; Wohl P; Spicak J; Drastich P World J Gastroenterol; 2017 Jul; 23(25):4548-4558. PubMed ID: 28740343 [TBL] [Abstract][Full Text] [Related]
47. Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. Gophna U; Sommerfeld K; Gophna S; Doolittle WF; Veldhuyzen van Zanten SJ J Clin Microbiol; 2006 Nov; 44(11):4136-41. PubMed ID: 16988016 [TBL] [Abstract][Full Text] [Related]
48. Detection of enterotoxigenic Zamani S; Hesam Shariati S; Zali MR; Asadzadeh Aghdaei H; Sarabi Asiabar A; Bokaie S; Nomanpour B; Sechi LA; Feizabadi MM Gut Pathog; 2017; 9():53. PubMed ID: 28924454 [TBL] [Abstract][Full Text] [Related]
49. Fecal microbiome from patients with ulcerative colitis is potent to induce inflammatory responses. Wang S; Yao L; Liu Y Int Immunopharmacol; 2018 Jun; 59():361-368. PubMed ID: 29684823 [TBL] [Abstract][Full Text] [Related]
50. Characterizing the composition of intestinal microflora by Wang WJ; Zhou YL; He J; Feng ZQ; Zhang L; Lai XB; Zhou JX; Wang H World J Gastroenterol; 2020 Feb; 26(6):614-626. PubMed ID: 32103871 [TBL] [Abstract][Full Text] [Related]
51. VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice. Wang CS; Li WB; Wang HY; Ma YM; Zhao XH; Yang H; Qian JM; Li JN World J Gastroenterol; 2018 Oct; 24(37):4254-4262. PubMed ID: 30310258 [TBL] [Abstract][Full Text] [Related]
52. Moxibustion treatment modulates the gut microbiota and immune function in a dextran sulphate sodium-induced colitis rat model. Qi Q; Liu YN; Jin XM; Zhang LS; Wang C; Bao CH; Liu HR; Wu HG; Wang XM World J Gastroenterol; 2018 Jul; 24(28):3130-3144. PubMed ID: 30065559 [TBL] [Abstract][Full Text] [Related]
53. Development of an XBP1 agonist, HLJ2, as a potential therapeutic agent for ulcerative colitis. Zhang H; Zhang Z; Song G; Tang X; Song H; Deng A; Wang W; Wu L; Qin H Eur J Pharm Sci; 2017 Nov; 109():56-64. PubMed ID: 28757346 [TBL] [Abstract][Full Text] [Related]
55. Molecular profiling of mucosal tissue associated microbiota in patients manifesting acute exacerbations and remission stage of ulcerative colitis. Walujkar SA; Kumbhare SV; Marathe NP; Patangia DV; Lawate PS; Bharadwaj RS; Shouche YS World J Microbiol Biotechnol; 2018 May; 34(6):76. PubMed ID: 29796862 [TBL] [Abstract][Full Text] [Related]
56. Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis. Matsuda H; Fujiyama Y; Andoh A; Ushijima T; Kajinami T; Bamba T J Gastroenterol Hepatol; 2000 Jan; 15(1):61-8. PubMed ID: 10719749 [TBL] [Abstract][Full Text] [Related]
57. Cross-Talk Between Butyric Acid and Gut Microbiota in Ulcerative Colitis Following Fecal Microbiota Transplantation. Xu HM; Huang HL; Xu J; He J; Zhao C; Peng Y; Zhao HL; Huang WQ; Cao CY; Zhou YJ; Zhou YL; Nie YQ Front Microbiol; 2021; 12():658292. PubMed ID: 33912150 [TBL] [Abstract][Full Text] [Related]
58. [Changes of fecal flora and its correlation with inflammatory indicators in patients with inflammatory bowel disease]. Zhang T; Chen Y; Wang Z; Zhou Y; Zhang S; Wang P; Xie S; Jiang B Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1474-7. PubMed ID: 24144750 [TBL] [Abstract][Full Text] [Related]
59. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease. Nishino K; Nishida A; Inoue R; Kawada Y; Ohno M; Sakai S; Inatomi O; Bamba S; Sugimoto M; Kawahara M; Naito Y; Andoh A J Gastroenterol; 2018 Jan; 53(1):95-106. PubMed ID: 28852861 [TBL] [Abstract][Full Text] [Related]
60. [Correlation analysis between type 2 diabetes and core gut microbiota]. Xiao Y; Niu Y; Mao M; Lin H; Wang B; Wu E; Zhao H; Li S Nan Fang Yi Ke Da Xue Xue Bao; 2021 Mar; 41(3):358-369. PubMed ID: 33849826 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]